Longevity & AgingResearch PaperOpen Access

Rutin Flavonoid Protects Liver Cells From Ketosis-Related Damage in Calves

Natural compound rutin shields calf liver cells from oxidative stress caused by elevated ketone bodies, offering potential therapeutic insights.

Friday, April 10, 2026 0 views
Published in Int J Mol Sci
Microscopic view of healthy liver cells glowing with protective antioxidant activity, surrounded by molecular structures of rutin flavonoid

Summary

Researchers found that rutin, a natural flavonoid found in buckwheat and citrus fruits, protects calf liver cells from damage caused by β-hydroxybutyric acid (BHBA), a ketone body that accumulates during negative energy balance in dairy cows. The study used primary calf hepatocytes exposed to BHBA to model ketosis-related liver injury. Rutin pretreatment significantly reduced oxidative stress markers like malondialdehyde and reactive oxygen species while boosting antioxidant defenses including glutathione and catalase activity. The protective effects occurred through activation of the Keap1/Nrf2 antioxidant pathway and metabolic reprogramming involving fatty acid metabolism.

Detailed Summary

This study addresses a critical problem in dairy farming where cows experience negative energy balance during peak lactation, leading to excessive ketone body production and liver damage. Ketosis affects approximately 15% of dairy cows, significantly impacting production efficiency and animal welfare.

Researchers used primary calf hepatocytes to investigate whether rutin, a natural flavonoid with known antioxidant properties, could protect against BHBA-induced liver cell damage. They exposed cells to 1.2 mM BHBA for 24 hours to simulate ketosis conditions, then tested various concentrations of rutin pretreatment.

The results were striking. BHBA exposure significantly increased oxidative stress markers including malondialdehyde (220% reduction with rutin), nitric oxide, and reactive oxygen species, while decreasing protective glutathione levels and catalase activity. Rutin pretreatment at 100-150 μg/mL effectively reversed these harmful changes, with 100 μg/mL showing the greatest glutathione recovery (180% increase).

Mechanistically, the study revealed that rutin works through the Keap1/Nrf2 signaling pathway, a master regulator of cellular antioxidant defenses. BHBA treatment upregulated the repressor protein Keap1 while downregulating protective factors Nrf2, NQO1, and HO-1. Rutin pretreatment reversed these changes, restoring the cell's natural antioxidant machinery.

Advanced metabolomics analysis identified 1,525 metabolites and revealed that rutin's protection involves metabolic reprogramming. The compound restored levels of beneficial metabolites like linolenic acid and betaine while reducing harmful oxidative stress markers like 8-hydroxy-2'-deoxyguanosine. Pathway analysis indicated that fatty acid degradation was the primary metabolic route through which rutin exerted its protective effects.

These findings suggest rutin could be developed as a therapeutic intervention for ketosis in dairy cows, potentially improving animal health and dairy production efficiency. However, the study was limited to cell culture models and requires in vivo validation.

Key Findings

  • Rutin reduced oxidative stress markers by up to 220% in BHBA-exposed calf liver cells
  • Protection occurred via Keap1/Nrf2 antioxidant pathway activation
  • Metabolomics revealed fatty acid degradation as key protective mechanism
  • 100-150 μg/mL rutin concentrations showed optimal hepatoprotective effects
  • Treatment restored beneficial metabolites while reducing oxidative damage markers

Methodology

Primary calf hepatocytes were exposed to 1.2 mM β-hydroxybutyric acid for 24 hours to model ketosis-induced liver injury. Various rutin concentrations (50-150 μg/mL) were tested as pretreatments, with outcomes measured via oxidative stress markers, gene/protein expression, and untargeted metabolomics analysis.

Study Limitations

Study was conducted only in isolated calf liver cells, not living animals. Results need validation in whole-animal models before clinical application. The optimal dosing, delivery method, and safety profile for in vivo use remain to be determined.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.